L051823 DICER1 Virtual Symposium
Join us virtually for the 2023 DICER1 Symposium to discuss the latest findings in DICER1 and PPB clinical and laboratory research.
Healthcare professionals and researchers dedicated to improving outcomes for children and adults with DICER1-related conditions.
- Identify DICER1-specific ACMG/AMP variant classification guidelines
- Share clinical updates in DICER1-related cancers
- Share updates in DICER1-related laboratory research
- Provide opportunities for multidisciplinary discussion
*Agenda may be subject to change*
May 18, 2023
|Presentation with speaker(s)
9:00AM – 9:10AM CST
9:10AM – 9:40AM CST
|DICER1-specific modifications to the ACMG/AMP variant classification guidelines improve analysis of germline DICER1 variants with Jessica Hatton, MS, CGC
9:40AM – 10:00AM CST
|Clinical updates from the International PPB/DICER1 Registry with Kris Ann Schultz, MD
10:00AM – 10:20AM CST
|DICER1 the Israeli Experience with Tal Ben-Ami, MD & Orli Michaeli, MD
10:20AM – 10:30AM CST
10:30AM – 10:50AM CST
Development of liver-specific DICER1 syndrome model mouse with Shin-ichiro Ohno, PhD & Masahiko Kuroda, MD, PhD
10:50AM – 11:10AM CST
|A genetically true model of DTPS as a platform for translational research with David Huntsman, MD
11:10AM – 11:30AM CST
|DICER1 deficiency in retinal disease with Bradley Gelfand, PhD
11:30AM – 11:50PM CST
|Cell and zebrafish approaches to studying DICER1 tumor predisposition syndrome with Mona Wu, PhD
|11:50AM - 12:10PM CST
|Germline DICER1 loss promotes rhabdomyosarcoma via innate immune system with Randy Larsen, MS
12:10PM – 12:30PM CST
|Pineoblastoma: An imbalance between growth and differentiation with Kenneth Chen, MD
|12:30 PM – 1:00PM CST
|Questions and Roundtable Discussion
It is our intent that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It is not assumed any potential conflicts will have an adverse impact on these presentations. It remains for the audience to determine whether the speaker’s outside interest may reflect a possible bias, either the exposition or the conclusions presented.
The following presenter(s) have disclosed they have a relevant financial relationship with an ineligible company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients and have disclosed that a conflict of interest exists with the presentation. An explanation of how the conflict is being mitigated is listed below.
Bradley Gelfand, PhD has disclosed that he is co-founder of DiceRx which currently has no assets and all relevant financial relationships have been mitigated.
All other planning committee members and presenters have disclosed they have no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients and have disclosed that no conflict of interest exists with the presentation/educational event.
Tal Ben-Ami, MD, Head of Pediatric Hematology-Oncology Unit, Kaplan Medical Center, Rehovot, Israel
Kenneth Chen, MD, Center for Cancer and Blood Disorders, University of Texas- Southwestern
Bradley Gelfand, PhD, Associate Professor of Ophthalmology, University of Virginia
Jessica Hatton, MS, CGC, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
David Huntsman, MD, Director of Ovcare & Distinguished Scientist, Deputy Department Head, BC Cancer Agency Research Centre
Masahiko Kuroda, MD, PhD, Department of Molecular Pathology, Tokyo Medical University, Tokyo, 160-8402, Japan
Randy Larsen, MS, St. Jude Graduate School of Biomedical Science
Orli Michaeli, MD, Division of Hematology/Oncology, Schneider Children’s Medical Center of Israel
Shin-ichiro Ohno, PhD, Department of Molecular Pathology, Tokyo Medical University, Tokyo, 160-8402, Japan
Kris Ann Schultz, MD, International PPB/DICER1 & OTST Registries, Cancer and Blood Disorders, Children’s Minnesota
Mona Wu, PhD, Postdoctoral Research Fellow, Amatruda Lab, Division of Hematology-Oncology, Cancer and Blood Disease Institute, University of Southern California/ Children’s Hospital of Los Angeles
In support of improving patient care, Children’s Minnesota is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Children’s Minnesota takes responsibility for the content, quality and scientific interest of its accredited continuing education events.
Children’s Minnesota designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent to their participation in the activity.
This program offers 3.5 contact hours of continuing education. Most medical professional organizations accept AMA PRA Category 1 Credits™. It is the individual’s responsibility to determine whether an education activity meets the continuing education requirements of their respective licensures and/or professional boards. Go to your respective organization’s website for more detailed information regarding credit requirements.
- 3.50 AMA PRA Category 1 Credit™
- 3.50 Attendance
- 3.50 Approved AMA PRA Category 1 Credit™
Please click on the TAKE COURSE button to get started. You will navigate through the course pages by clicking the START COURSE or by accessing the content using the left-hand side navigation pane.
Children's Minnesota employees only
To add this event to your calendar, please follow these steps:
- Open your confirmation email from this course
- Click the add to calendar link (this will download the .ics file to your computer)
- Open your Outlook calendar
- Select "Add calendar" from the left pane just above My Calendars
- Select "Upload from file" in the Add calendar window.
- Select Browse, go to your Downloads folder and select the .ics file.
- Select the Calendar you want the appointment to show up in, typically Calendar and then select Import.
You will need a computer, iPad, or device with internet access to attend.